PDCD1 and neoplasm: Preclinical data support that RT-associated increases in the CD8+ T-cell/Treg ratio, CD8+ T-cell PD-1 expression, and tumor cell PD-L1 expression often occur early with peak levels occurring within 24–96 h post-RT [81, 86].